Stellate Ganglion Block for PTSD (SGB-PTSD)
Efficacy and Safety of Stellate Ganglion Block for Post-traumatic Stress Disorder in Veterans
Sponsor: Analydata, Inc.
A NA clinical study on Post-traumatic Stress Disorder, this trial is ongoing. The trial is conducted by Analydata, Inc. and has accumulated 14 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Jan 2026 — Present [monthly]
Active Not Recruiting NA
-
Dec 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2025 — Dec 2025 [monthly]
Recruiting NA
-
Sep 2025 — Oct 2025 [monthly]
Recruiting NA
-
Jun 2025 — Sep 2025 [monthly]
Recruiting NA
▶ Show 9 earlier versions
-
Feb 2025 — Jun 2025 [monthly]
Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
-
Nov 2022 — Sep 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting NA
-
Feb 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
Phase: PHASE2_PHASE3 → NA
-
Jan 2022 — Feb 2022 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Analydata, Inc.
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .